Labostro, Rhine .

HRN: 25-41-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2024
CEFUROXIME 1.5GM (VIAL)
07/01/2024
07/07/2024
IV
550mg
Q8
UTI
Waiting Final Action 
07/01/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/01/2024
07/10/2024
PO
7ml
TID
Amoebiasis
Waiting Final Action 
07/01/2024
MUPIROCIN 2%, 15G (TUBE)
07/01/2024
07/07/2024
TOPICAL
2%
BID
Skin Lesions
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: